Photodynamic Therapy Combined with Intravitreal Bevacizumab in a Patient with Choroidal Neovascularization Secondary to Choroidal Osteoma.
10.3341/kjo.2012.26.6.478
- Author:
Jung Hyun JANG
1
;
Keong Hwan KIM
;
Soo Jung LEE
;
Jung Min PARK
Author Information
1. Department of Ophthalmology, Maryknoll Medical Center, Busan, Korea. pjm1438@hanmail.net
- Publication Type:Case Reports
- Keywords:
Bevacizumab;
Choroidal osteoma;
Photochemotherapy
- MeSH:
Angiogenesis Inhibitors/administration & dosage;
Antibodies, Monoclonal, Humanized/*administration & dosage;
Choroid Neoplasms/*complications/diagnosis;
Choroidal Neovascularization/diagnosis/*drug therapy/etiology;
Female;
Fluorescein Angiography;
Humans;
Intravitreal Injections;
Middle Aged;
Osteoma/*complications/diagnosis;
Photochemotherapy/*methods;
Tomography, Optical Coherence;
Vascular Endothelial Growth Factor A/antagonists & inhibitors;
Visual Acuity
- From:Korean Journal of Ophthalmology
2012;26(6):478-480
- CountryRepublic of Korea
- Language:English
-
Abstract:
Choroidal osteoma is a benign ossified tumor that is found predominantly in healthy young women during their second and third decades of life. The lesions are white-to-cream or orange in color, are located in the peripapillary and macular areas, and are unilateral in most patients. The symptoms of choroidal osteoma include decreased visual acuity and metamorphopsia or scotoma corresponding to the location of the osteoma, but some patients have no symptoms. Prognosis of vision varies according to tumor location, retinal pigment epithelial and sensory retinal degeneration, subretinal fluid and hemorrhage, and development of a subretinal neovascular membrane.
